Toxoplasmosis is an infection brought about by the Toxoplasma gondii parasite. It can be diagnosed through either serologic testing or molecular testing.
To continue booking, you need to select at least 1 test
* Results are available same day by 9 p.m. 99% of the time. On rare occasions, it may take up to 3 business days to receive results.
T. gondii is a microscopic parasite, invisible to the naked eye. In the majority of healthy individuals, the infection either remains asymptomatic or leads to a mild flu-like illness. Nevertheless, when a pregnant woman becomes infected and transmits it to her unborn child, or when an individual with a compromised immune system (immunocompromised) contracts the infection, the parasite can give rise to severe complications.
In cases where a pregnant woman or an immunocompromised individual has been exposed to T. gondii and experiences flu-like symptoms or exhibits signs of a severe eye or brain infection, prompting concern from a healthcare provider regarding possible toxoplasmosis infection, medical attention is warranted.
A blood sample is typically obtained from a vein; in rare instances, a cerebrospinal fluid (CSF) sample may be gathered through a procedure known as a lumbar puncture or spinal tap. Alternatively, in the case of a pregnant woman, an amniotic fluid sample can be collected through amniocentesis. No special Preparation is Needed.
T. gondii, a microscopic parasite, remains unseen to the naked eye. In most healthy individuals, infection either goes unnoticed or results in a mild flu-like illness. However, when a pregnant woman contracts the parasite and transmits it to her unborn child or when an individual with a weakened immune system (immunocompromised) becomes infected, severe complications can ensue.
T. gondii has a global presence, with up to 60% of the population in some countries being affected. In the United States, the Centers for Disease Control and Prevention estimates that over 40 million people carry the infection, with approximately 11% of those aged 6 and older having had toxoplasmosis. Transmission can occur through various means, including:
The primary hosts for T. gondii are domestic and wild cats. In cats, the parasite multiplies after they consume infected birds, rodents, or contaminated raw meat, leading to the formation of eggs encased in protective coverings (oocysts). During an active infection, millions of microscopic eggs can be released into the cat's stool for several weeks. These eggs become infective within days and can remain viable for several months. However, in all other hosts, including humans, T. gondii goes through a limited portion of its lifecycle, forming dormant cysts in muscles, the brain, and eyes. The host's immune system keeps these cysts in check, preventing further infection. The dormant stage can persist for the host's lifetime unless their immune system is compromised.
In individuals with weakened immune systems, such as those with HIV/AIDS, undergoing chemotherapy, recent organ transplant recipients, or on immunosuppressant medications, an initial or reactivated T. gondii infection can lead to significant symptoms and complications. It can affect the nervous system and eyes, resulting in headaches, seizures, confusion, fever, encephalitis, loss of coordination, and blurred vision.
Pregnant women who become infected face a 30-40% risk of passing the infection to their unborn child. If the congenital infection occurs early in the pregnancy, it can lead to miscarriages, stillbirths, or severe complications in the newborn, including mental retardation, seizures, blindness, and an enlarged liver or spleen. Many infected babies, especially those exposed later in pregnancy, may appear healthy at birth but may develop symptoms such as severe eye infections, hearing loss, and learning disabilities in the years that follow.
A toxoplasmosis test serves to identify a current or past infection involving the microscopic parasite Toxoplasma gondii. It is commonly conducted for the following reasons:
Various testing methods are available for detecting T. gondii. The selection of tests and samples collected is contingent on the individual, their symptoms, and the clinical judgment of the healthcare provider.
Caution is essential when interpreting the outcomes of toxoplasmosis testing. In cases of immunocompromised individuals, the antibody response to a T. gondii infection might be weak, resulting in lower-than-expected levels of IgM and IgG, even when they have an ongoing case of toxoplasmosis.
Also, False positives are a possibility. Typically, when IgM antibody tests yield positive results, it is advisable to confirm these findings through an alternative testing method, often by sending the sample to a specialized reference laboratory that focuses on toxoplasmosis testing.
In newborns, IgM antibodies are the sole class of antibodies produced. The presence of Toxoplasma IgM antibodies in a newborn signifies a congenital infection.
T. gondii is not typically transmitted directly from one person to another, except in cases of mother-to-child transmission. Almost all instances of infection result from the consumption, ingestion, or handling of contaminated items.
Treatment is generally unnecessary for most healthy individuals, but options are available for those with weakened immune systems, pregnant women to reduce the risk of fetal transmission, and newborns with congenital toxoplasmosis. For further information on treatment, you can refer to the Mayo Clinic or CDC websites.
Here are the recommended actions to take:
Additional tests, including the IgG avidity test, may be conducted by a reference laboratory to provide further confirmation of a T. gondii infection. In rare instances, a tissue sample from a suspected Toxoplasma parasite-infected area may be obtained through biopsy. This sample can undergo culturing and/or staining and examination under a microscope to detect the presence of the parasite. Typically, these procedures are reserved for challenging diagnostic cases.
Best Prices
Our fully automated private laboratory with cutting edge technology is able to reduce costs while increasing consistency and reproducibility of results.
Faster Service
We have designed our clinics and testing processes to be efficient, reducing wait times and time for results.
More Precise Information
Our test reports provide more precise information on test results, making it easier to monitor any changes in your health over time.
Free Parking
All our clinics provide free and available parking, helping you to save even more money and time.
Customer Support
Our online booking portal and helpful testing center staff help to make diagnostic testing more convenient and compassionate.
IMPLEMENT AFFORDABLE ACTION
Companies and institutions can deploy large-scale diagnostic testing at a fraction of the cost of testing centers with Lilium’s automated laboratory testing platforms and reporting.
STAY AHEAD OF OUTBREAKS
Lilium's pioneering testing system secures workplaces and communities against expensive shutdowns by keeping businesses and organizations ahead of outbreaks.
REDUCE RISKS
Robotic analysis improves accuracy of results by drastically reducing the risk of false negatives and positives.
To make an appointment, please choose from one of our clinics below:
Monday - Saturday
7:00 - 10:00
12:00 - 15:00
We provide FREE parking at our convenient locations
Our downtown Montreal location is located on the mezzanine level of the Alexis Nihon Center with 1 hour free indoor parking. Atwater metro station has a direct inside connection to Alexis Nihon.
If you’re driving to our Laval location, we are right off Autoroute 15 and have plenty of free parking.
If you arrive by public metro, there is a walkway to our lab from Metro Montmorency (a 20 minute walk).
What our customers say about us
ASK US ANYTHING
We're here to help make sense of it all.
Or send us an e-mail